ArticleJournal of pain research2026
Efficacy and Safety of Acupuncture for Pain in Non-Small Cell Lung Cancer: A Meta-Analysis.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Lung cancer remains the primary cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) accounting for most cases. Although acupuncture has been used for cancer pain management, its efficacy remains controversial due to varying results from clinical studies. This study aims to evaluate the efficacy and safety of acupuncture for managing pain in patients with non-small cell lung cancer (NSCLC). Methods: A literature search was conducted across eight major databases up to September 3, 2024. Two reviewers independently screened studies, extracted data, and assessed risk of bias following Cochrane guidelines. RevMan software was employed to calculate risk ratios and standardized mean differences (SMD) with 95% confidence intervals (CI), using fixed or random-effects models based on the heterogeneity observed. Subgroup analyses, sensitivity analyses, publication bias assessment (funnel plots and Egger's test), evidence quality rating, and trial sequential analysis (TSA) were performed. Results: Eleven randomized controlled trials incorporating 745 NSCLC patients were included in the meta-analysis. The primary outcomes assessed included pain intensity and adverse events. The meta-analysis revealed that acupuncture significantly outperformed medical treatments in reducing pain intensity (SMD=-1.33, 95% CI [-2.02, -0.63]) and incidence of adverse events (OR = 0.25, 95% CI [0.14, 0.43]). Compared to medical treatment, acupuncture showed benefits in improving total effective rate (OR=3.30, 95% CI [1.15, 9.46]) and reducing symptoms of anorexia (SMD=-0.40, 95% CI [-0.74, -0.06]), insomnia (SMD=-0.67, 95% CI [-1.03, -0.31]) and fatigue (SMD=-1.18, 95% CI [-2.04, -0.33]) compared to medical treatments. Sensitivity analyses validated result robustness. No significant publication bias was detected via funnel plots and Egger tests. TSA confirmed sufficient sample sizes for pain intensity, fatigue, and insomnia outcomes. Conclusion: Acupuncture has demonstrated positive effects in alleviating cancer pain in patients with NSCLC, contributing to an improved quality of life while maintaining a certain level of safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.